Cardiovascular Systems (CSII) Upgraded at BidaskClub

Cardiovascular Systems (NASDAQ:CSII) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a research note issued on Friday.

Several other brokerages also recently commented on CSII. ValuEngine raised Cardiovascular Systems from a “sell” rating to a “hold” rating in a report on Wednesday. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardiovascular Systems in a report on Thursday, May 3rd. Leerink Swann cut their target price on Cardiovascular Systems from $31.00 to $30.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. Finally, Zacks Investment Research downgraded Cardiovascular Systems from a “buy” rating to a “hold” rating in a report on Monday, February 12th. One analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the stock. Cardiovascular Systems presently has an average rating of “Hold” and an average target price of $27.00.

Shares of Cardiovascular Systems opened at $30.15 on Friday, according to Marketbeat. The stock has a market cap of $967.81 million, a price-to-earnings ratio of 1,005.00 and a beta of 2.18. Cardiovascular Systems has a 12 month low of $29.38 and a 12 month high of $29.70. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.99 and a current ratio of 4.46.

Cardiovascular Systems (NASDAQ:CSII) last announced its earnings results on Wednesday, May 2nd. The medical device company reported $0.01 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.02) by $0.03. The firm had revenue of $55.59 million for the quarter, compared to the consensus estimate of $55.63 million. Cardiovascular Systems had a negative return on equity of 1.03% and a negative net margin of 0.59%.

Large investors have recently made changes to their positions in the company. Renaissance Technologies LLC lifted its stake in shares of Cardiovascular Systems by 69.7% in the 4th quarter. Renaissance Technologies LLC now owns 899,300 shares of the medical device company’s stock valued at $21,304,000 after purchasing an additional 369,500 shares during the period. Brown Capital Management LLC lifted its stake in shares of Cardiovascular Systems by 7.0% in the 4th quarter. Brown Capital Management LLC now owns 2,659,509 shares of the medical device company’s stock valued at $63,004,000 after purchasing an additional 173,271 shares during the period. Bank of Montreal Can lifted its stake in shares of Cardiovascular Systems by 12.5% in the 4th quarter. Bank of Montreal Can now owns 53,889 shares of the medical device company’s stock valued at $1,277,000 after purchasing an additional 5,998 shares during the period. Teacher Retirement System of Texas acquired a new position in shares of Cardiovascular Systems in the 4th quarter valued at about $273,000. Finally, Champlain Investment Partners LLC lifted its stake in shares of Cardiovascular Systems by 21.3% in the 4th quarter. Champlain Investment Partners LLC now owns 2,253,355 shares of the medical device company’s stock valued at $53,382,000 after purchasing an additional 396,145 shares during the period. 81.51% of the stock is currently owned by institutional investors.

About Cardiovascular Systems

Cardiovascular Systems, Inc, a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States. The company offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System (OAS), Diamondback 360 60cm Peripheral OAS, Diamondback 360 4 French 1.25 Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, Diamondback 360 2.00 Peripheral OAS, and Stealth 360 Peripheral OAS, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives.

Analyst Recommendations for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit